Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26 |...

Dununu.com Dununu

Patrocinados

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26

RSS Feed Business

Posted

54

India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.

Read Full Article

Please log in to like, share and comment!

MLC: Gous, Maxwell power WF to six-wicket win over MINY; finish top two

Andries Gous's composed innings and Glenn Maxwell's excellent bowling performance led Washington...

By 0 1

'Essence of the game goes missing': Shubman Gill slams Dukes ball, flat pitches

Shubman Gill, despite his stellar batting performance in the series with nearly 600 runs, has...

By 0 1

'It's not over for us': US coast guard saves 165 lives in Texas flash floods; hailed as 'American hero'

By 0 8

Top stocks to buy or sell today: Stock recommendations for July 7, 2025 - here's what brokerages are saying

Nuvama downgraded Trent, while Morgan Stanley held an underweight rating on Bank of Baroda due to...

By 0 8

India’s nominal GDP may hit a six-year low: Report

Jefferies projects a slowdown in India's corporate revenue and earnings growth for FY26 due to an...

By 0 10